https://orcid.org/0000-0001-7357-1654
References
- Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361(10):968–979.
- Gilpin D, Coleman S, Hall S, et al. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease. J Hand Surg Am. 2010;35(12):2027–2038.
- Witthaut J, Jones G, Skrepnik N, et al. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg Am. 2013;38(1):2–11.
- Warwick D, Arner M, Pajardi G, et al. Collagenase Clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes. J Hand Surg Eur Vol. 2015;40(2):124–132.
- Peimer CA, Blazar P, Coleman S, et al. Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am. 2013;38(1):12–22.
- Peimer C, Blazar P, Coleman S, et al. Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [collagenase option for reduction of Dupuytren long-term evaluation of safety study]): 5-year data. J Hand Surg Am. 2015;40(8):1597–1605.
- Bainbridge C, Gerber RA, Szczypa PP, et al. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. J Plast Surg Hand Surg. 2012;46(3–4):177–183.
- Rodrigues JN, Zhang W, Scammell BE, et al. Dynamism in Dupuytren's contractures. J Hand Surg Eur Vol. 2015;40(2):166–170.
- De Salas-Cansado M, Cuadros M, Del Cerro M, et al. Budget impact analysis in Spanish patients with Dupuytren's contracture: fasciectomy vs. collagenase Clostridium histolyticum. Chir Main. 2013;32(2):68–73.
- Sanjuan-Cerveró R, Franco-Ferrando N, Poquet-Jornet J. Use of resources and costs associated with the treatment of Dupuytren’s contracture at an orthopedics and traumatology surgery department in Denia (Spain): collagenase Clostridium hystolyticum versus subtotal fasciectomy. BMC Musculoskelet Disord. 2013;14:293.
- Coleman S, Gilpin D, Kaplan FT, et al. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J Hand Surg Am. 2014;39(1):57–64.
- Gaston RG, Larsen SE, Pess GM, et al. The efficacy and safety of concurrent collagenase Clostridium histolyticum injections for 2 dupuytren contractures in the same hand: a prospective, multicenter study. J Hand Surg Am. 2015;40(10):1963–1971.
- Verheyden JR. Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique. J Hand Surg Eur Vol. 2015;40(2):133–140.
- Warwick D. Dupuytren's disease: my personal view. J Hand Surg Eur Vol. 2017;42(7):665–672.
- Sanjuan-Cerveró R, Vazquez-Ferreiro P, Gomez-Herrero D, et al. Efficacy of collagenase Clostridium histolyticum for dupuytren disease: a systematic review. Rev Iberoam Cir Mano. 2017;45(02):070–088.
- Leclère FM, Mathys L, Vögelin E. Collagenase injection in Dupuytren's disease, evaluation of the ultrasound assisted technique. Chir Main. 2014;33(3):196–203.
- Strömberg J, Vanek P, Fridén J, et al. Ultrasonographic examination of the ruptured cord after collagenase treatment or needle fasciotomy for Dupuytren's contracture. J Hand Surg Eur Vol. 2017;42(7):683–688.
- Badalamente MA, Hurst LC. Development of collagenase treatment for Dupuytren disease. Hand Clin. 2018;34(3):345–349.